Afuco™ Anti-SELP ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-015ML) (CAT#: AFC-TAB-015ML)
This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to SELP. It is a human monoclonal antibody that can be potentially used in the treatment of Sickle Cell Disease (SCD).
We specialize in custom recombinant antibody production, offering seamless execution from provided sequences to high-quality antibody deliverables, ensuring optimal yield and purity.

(Endothelial cells
Staining: Medium
Intensity: Strong
Quantity: <25%
Location: Cytoplasmic/membranous)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/images/2145/5903_A_9_3.jpg

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000174175-SELP

(Cell lines ordered by descending RNA expression order.)
* Image credit: Human Protein Atlas https://v21.proteinatlas.org/ENSG00000174175-SELP
Specifications
- Immunogen
- The details of the immunogen for this antibody are not available.
- Host Species
- Human
- Derivation
- Humanized
- Type
- ADCC enhanced antibody
- Specificity
- Human SELP
- Species Reactivity
- Human
- Applications
- ELISA, IHC, FC, IP, IF, FuncS
- Conjugate
- Unconjugated
- Generic Name
- Crizanlizumab
- Related Disease
- Sickle Cell Disease (SCD)
Product Property
- Purity
- >95% by SDS-PAGE
- Storage
- Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.
Target
Product Notes
This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:
• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production
See more details about Hi-Affi™ recombinant antibody benefits.
Downloads
Download resources about recombinant antibody development and antibody engineering to boost your research.
See other products for "Crizanlizumab"
DrugMonitor™ Anti-Crizanlizumab Antibody (VS-1224-YC317)Crizanlizumab is a humanized IgG2 monoclonal antibody used to reduce vaso-occlusive crisis frequency in sickle cell disease patients. The DrugMonitor™ Anti-Crizanlizumab Antibody (VS-1224-YC317) is an anti-drug antibody (ADA) against Crizanlizumab. This drug-based antibody is raised in mice immunized with the Crizanlizumab. The anti-Crizanlizumab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Crizanlizumab in samples.
See other products for "SELP"
Select a product category from the dropdown menu below to view related products.
CAT | Product Name | Application | Type |
---|---|---|---|
TAB-246 | Anti-Human selectin P Recombinant Antibody (Inclacumab) | ELISA, FC, IP, FuncS, IF, Neut, ICC | IgG4 - kappa |
Customer Reviews and Q&As
There are currently no Customer reviews or questions for AFC-TAB-015ML. Click the button above to contact us or submit your feedback about this product.
Popular products with customers
Application: ELISA, IP, FC, FuncS, Neut, IF, ICC
Application: FuncS, IF, Neut, ELISA, FC, IP, IHC
Application: IF, IP, Neut, FuncS, ELISA, FC, ICC
Application: ELISA, FC, IP, FuncS, IF, Neut, ICC
Application: ELISA
Application: ELISA, IHC, FC, IP, IF, FuncS
Application: WB, ELISA, IHC, IP, SPR, FuncS
Application: FC, IA, IF, IP, IHC, FuncS
For Research Use Only. Not For Clinical Use.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.